Cerenome (CNSY) Cost of Revenue (2011 - 2018)
Analysis
Cerenome (CNSY) Cost of Revenue (2011 - 2018) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cost of Rev (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 141.52 Bn | 133.66 Bn | 2.84 Bn | 489.20 Mn |
| 2 | Regeneron Pharmaceuticals | 86.69 Bn | 78.69 Bn | 3.93 Bn | 360.70 Mn |
| 3 | Argenx Se | 64.63 Bn | 59.45 Bn | 1.37 Bn | 145.00 Mn |
| 4 | Moderna | 59.30 Bn | 54.16 Bn | 52.00 Mn | 93.00 Mn |
| 5 | Revolution Medicines | 44.41 Bn | 44.41 Bn | - | - |
| 6 | BeOne Medicines | 40.45 Bn | 35.35 Bn | 1.53 Bn | 174.53 Mn |
| 7 | Alnylam Pharmaceuticals | 35.29 Bn | 31.98 Bn | 992.69 Mn | 298.26 Mn |
| 8 | Royalty Pharma | 28.44 Bn | 27.60 Bn | - | - |
| 9 | Insmed | 27.55 Bn | 26.39 Bn | 358.27 Mn | 67.21 Mn |
| 10 | Cerenome | 20.42 Mn | 11.83 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2018 | 628,000.00 |
| Jun 30, 2018 | 630,000.00 |
| Mar 31, 2018 | 579,000.00 |
| Dec 31, 2017 | 633,000.00 |
| Sep 30, 2017 | 487,000.00 |
| Jun 30, 2017 | 707,000.00 |
| Mar 31, 2017 | 716,000.00 |
| Dec 31, 2016 | 945,000.00 |
| Sep 30, 2016 | 618,000.00 |
| Jun 30, 2016 | 585,000.00 |
| Mar 31, 2016 | 567,000.00 |
| Dec 31, 2015 | 791,000.00 |
| Sep 30, 2015 | 502,000.00 |
| Jun 30, 2015 | 1.30 Mn |
| Mar 31, 2015 | 598,000.00 |
| Dec 31, 2014 | 1.42 Mn |
| Sep 30, 2014 | 337,000.00 |
| Jun 30, 2014 | 766,000.00 |
| Mar 31, 2014 | 421,000.00 |
| Dec 31, 2013 | 1.13 Mn |